News
12/11-26
Today we have published a systematic review and meta-analysis comparing the avoidance versus use of neuromuscular blocking agents (NMBAs) for videolaryngoscopy-assisted tracheal intubation in Acta Anaesthesiologica Scandinavica.
The review included eight randomised clinical trials comprising 744 participants. The findings suggest a potentially increased risk of failed first-pass intubation when NMBAs are avoided. However, the evidence was of very low certainty, and no definitive conclusions could be drawn.
These findings highlight the need for further high-quality randomised trials to determine the optimal pharmacological strategy for videolaryngoscopy-assisted tracheal intubation.
The publication can be found here:
11/11-26
A great day in Lund! Skåne University Hospital Lund today randomised its first participant in the ROCVIDEO Trial, adding another active site to the trial.
Together with Södersjukhuset and Danderyd Hospital, we now have three active recruiting sites in Sweden.
Meanwhile, we have randomised 1,329 of the planned 2,684 participants across 22 sites in Denmark and Sweden, bringing us to almost halfway towards our recruitment target!
We are delighted with the continued progress and grateful to all participating sites and collaborators.
31/8-26
Today, we randomised our first participant in Sweden at Danderyd Hospital in Stockholm — an important milestone for the ROCVIDEO trial!
A big congratulations and thank you to our Swedish collaborators for all the work leading up to the start of recruitment. We are very excited to have Sweden on board and look forward to continuing the trial together.
Meanwhile, we have now randomised 991 participants, corresponding to 37% of the planned 2,684 participants.
17/6-26
We are pleased to share that the ROCVIDEO trial protocol has now been published in Acta Anaesthesiologica Scandinavica.
The full-text article is available here: https://onlinelibrary.wiley.com/doi/10.1111/aas.70277
We are also happy to announce that 726 participants have now been randomised across 15 active sites, corresponding to more than 25% of the target population.
Randomisation in Sweden is scheduled to begin in September 2026. We are very excited to expand the trial to Sweden.
13/3-26
We are pleased to share that our Scandinavian survey on pharmacological strategies and video laryngoscope use for non-acute tracheal intubation among Danish and Swedish anaesthesiologists has now been published in Acta Anaesthesiologica Scandinavica.
The survey explores current use of neuromuscular blocking agents, opioids, and video laryngoscopy in routine clinical practice. Importantly, the findings served as one of the supporting studies informing the design of the ROCVIDEO Trial.
The full-text article is available here: https://onlinelibrary.wiley.com/doi/10.1111/aas.70200
16/2-26
The topic investigated in the ROCVIDEO Trial has recently been debated in the Journal of the Danish Medical Association. With an initial opinion piece from a Danish anaesthesiologist describing a growing tendency among colleagues to perform tracheal intubation without neuromuscular blocking agents, contrary to current guidelines.
Today, we have published a response addressing the debate and highlighting the relevance of the ROCVIDEO Trial. At the same time, a representative from the Danish Society of Anaesthesiology and Intensive Care Medicine (DASAIM) has also published a response to the debate.
Initial opinion piece: https://ugeskriftet.dk/debat/intubation-uden-muskelrelaksantia-paa-vej-mod-en-praksisaendring-uden-evidens
DASAIMs response: https://ugeskriftet.dk/debat/svar-til-kronikken-intubation-uden-muskelrelaksantia-paa-vej-mod-en-praksisaendring-uden
Our response: https://ugeskriftet.dk/debat/kommentar-til-kronikken-intubation-uden-muskelrelaksantia-paa-vej-mod-en-praksisaendring-uden
All articles are in Danish.
10/2-26
Today, we reached an important milestone with the inclusion of participant number 200. The trial is currently active at eight sites, with an additional four sites scheduled to begin enrolment during February and March. Momentum is strong, and we are excited about the progress.
5/1-26
Holbæk Hospital has today randomised its first participant in the ROCVIDEO Trial. The milestone was reached in great spirits. A total of 94 participants have now been enrolled across seven active sites.
17/11-25
The first participant has been randomised at NOH.
11/11-25
One of the supporting studies of The ROCVIDEO Trial, was presented and won 2nd prize in best poster presentation at the World Airway Management Meeting 5-8th november 2025 in Florence. The poster was presented by first author and Steering Committee member Åse Lodenius. The final manuscript is awaiting publication.
22/9-25
ROCVIDEO has received regulatory approval from the Danish Medicines Agency and Research Ethics Committee.